Elsevier Announces Publication of Five New Books on Virology Including Second Edition of Adenoviral Vectors for Gene Therapy

Fully updated edition provides the latest coverage of gene delivery vehicles based on the adenovirus, now emerging as an important tool in gene therapy

Cambridge, MA, April 29, 2016

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of five new virology books including the second edition of the detailed, comprehensive resource Adenoviral Vectors for Gene Therapy, edited by David Curiel. This book covers the gene delivery vehicles based on the adenovirus, now emerging as an important tool in gene therapy. It highlights their potential uses for the treatment of disease with information on the construction, propagation and purification of adenoviral vectors.

The new edition provides complete coverage of the basic biology of adenoviruses. It introduces common strategies for the development of adenoviral vectors, along with cutting-edge methods for their improvement, and demonstrates noninvasive imaging of adenovirus-mediated gene transfer.

The book also discusses the utility of adenoviral vectors in animal disease models, and considers Federal Drug Administration regulations for human clinical trials.

  • Learn more about adenoviral vectors in this chapter about transductional targeting

Dr. Curiel is the Director of the Cancer Biology Division of the Department of Radiation Oncology at Washington University School of Medicine. His scientific training includes tenure at the National Institutes of Health in Bethesda, Maryland at the Pulmonary Branch of the Heart and Lung, and Blood Institute (NHLBI), and a fellowship in Biotechnology at the National Cancer Institute, Navy Medical Oncology Branch. In addition to his current role as Director of the Cancer Biology Division, he is Director of the Biologic Therapeutics Center.

In order to meet content needs in virology, Elsevier uses proprietary tools to identify the gaps in coverage of the topics. Editorial teams strategically fill those gaps with content written by key influencers in the field, giving students, faculty and researchers the content they need to answer challenging questions and improve outcomes. These new books, which will educate the next generation of virologists and provide critical foundational content for information professionals, are key examples of how Elsevier is enabling science to drive innovation.

The five new virology books are:


Notes for editors
E-book review copies of the new books are available to credentialed journalists upon request. Contact Robin Hayward at R.Hayward@elsevier.com.

About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com

Media contact
Pam Foote
Publicity Team, Science & Technology Books
+1 978 691 5572